Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Hospira Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (273)
Cancellation by sponsor (53)

Date

2024 (9)
2023 (7)
2022 (9)
2021 (30)
2020 (31)
2019 (28)
2018 (1)
2017 (5)
2016 (5)
2015 (4)
2014 (7)
2013 (14)
2012 (1)
2011 (10)
2010 (2)
2009 (16)
2008 (23)
2007 (61)
2006 (8)
2005 (23)
2004 (9)
2001 (2)
2000 (2)
1998 (3)
1997 (4)
1996 (1)
1994 (4)
1992 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

326 result(s) found, displaying 81 to 90

DBL VINORELBINE 50mg/5mL (as tartrate) concentrated injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL EPIRUBICIN HYDROCHLORIDE INJECTION epirubicin hydrochloride 50 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
HOSPIRA AMIKACIN INJECTION amikacin (as sulfate) 500mg/2mL solution for injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
HOSPIRA KETAMINE INJECTION ketamine (as hydrochloride) 200 mg/2 mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
HOSPIRA PENTAMIDINE ISETHIONATE FOR INJECTION pentamidine isetionate 300mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

1 October 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL HEPARIN SODIUM (PORCINE MUCOUS) 35000IU/ 35mL injection BP vial Cancelled under Section 30(1)(c) of the Act

21 September 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Calcium Folinate Injection 50 mg/5 mL vial (309207)

12 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Hospira Calcium Folinate Injection 50 mg/5 mL vial.
Hospira Cytarabine 20 mg/mL Injection 100 mg/5 mL vial Cancelled under Section 30(1)(c) of the Act

28 May 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
DBL cytarabine 500mg/25mL (preserved) injection vial Cancelled under Section 30(1)(c) of the Act

28 May 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Cytarabine Injection, 100 mg/5 mL vial Cancelled under Section 30(1)(c) of the Act

28 May 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.